DOT1L and neoplasm: The tumor size reduction in the cotreatment group did not involve HMGA2 downregulation in the tumors (Fig. S9), as epigenetic repression of DOT1L target genes would require continuous exposure to EPZ5676 as previously demonstrated [33].